INVESTOR RIGHTS AGREEMENT (AMENDED AND RESTATED AS OF DECEMBER 22, 2011)Investor Rights Agreement • August 7th, 2013 • Acceleron Pharma Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 7th, 2013 Company Industry JurisdictionThis Amended and Restated Investor Rights Agreement (this “Agreement”) is made as of December 22, 2011 by and among Acceleron Pharma Inc., a Delaware corporation (the “Corporation”) and the parties listed on Exhibit A hereto (the “Investors”).
INVESTOR RIGHTS AGREEMENT (AMENDED AND RESTATED AS OF DECEMBER 22, 2011)Investor Rights Agreement • July 3rd, 2013 • Acceleron Pharma Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJuly 3rd, 2013 Company Industry JurisdictionThis Amended and Restated Investor Rights Agreement (this “Agreement”) is made as of December 22, 2011 by and among Acceleron Pharma Inc., a Delaware corporation (the “Corporation”) and the parties listed on Exhibit A hereto (the “Investors”).